败血症
医学
革兰氏阳性菌
肺炎
肺炎链球菌
重症监护室
社区获得性肺炎
生物
克
降钙素原
免疫学
革兰氏阴性菌
内科学
免疫系统
病菌
微生物学
细菌
大肠杆菌
抗生素
基因
生物化学
遗传学
作者
Е. В. Переверзева,Fabrice Uhel,Hessel Peters‐Sengers,Joe M. Butler,Lonneke A. van Vught,Katie L. Burnham,Emma E. Davenport,Julian C. Knight,Olaf L. Cremer,Marcus J. Schultz,Marc J. M. Bonten,Brendon P. Scicluna,Tom van der Poll
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2021-08-26
卷期号:59 (3): 2101856-2101856
被引量:3
标识
DOI:10.1183/13993003.01856-2021
摘要
Background Gram-positive and Gram-negative bacteria are the most common causative pathogens in community-acquired pneumonia (CAP) on the intensive care unit (ICU). The aim of this study was to determine whether the host immune response differs between Gram-positive and Gram-negative CAP upon ICU admission. Methods 16 host response biomarkers providing insight into pathophysiological mechanisms implicated in sepsis and blood leukocyte transcriptomes were analysed in patients with CAP upon ICU admission in two tertiary hospitals in the Netherlands. Results 309 patients with CAP with a definite or probable likelihood (determined by predefined criteria) were included. A causative pathogen was determined in 74.4% of admissions. Patients admitted with Gram-positive CAP (n=90) were not different from those admitted with Gram-negative CAP (n=75) regarding demographics, chronic comorbidities, severity of disease and mortality. Host response biomarkers reflective of systemic inflammation, coagulation activation and endothelial cell function, as well as blood leukocyte transcriptomes, were largely similar between Gram-positive and Gram-negative CAP. Blood leukocyte transcriptomes were also similar in Gram-positive and Gram-negative CAP in two independent validation cohorts. On a pathogen-specific level, Streptococcus pneumoniae and Escherichia coli induced the most distinct host immune response. Conclusion Outcome and host response are similar in critically ill patients with CAP due to Gram-positive bacteria compared with Gram-negative bacteria.
科研通智能强力驱动
Strongly Powered by AbleSci AI